Thiabendazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500 mg
Reference Brands: Mintezol(US), Tebanic(EU)
Category: Anthelmintic
Thiabendazole inhibits microtubule formation in parasites, disrupting nutrient absorption and leading to their death. It effectively treats intestinal worms like roundworms and hookworms, as well as skin infestations. Benefits include rapid symptom relief, parasite eradication, reduced transmission, and supporting gastrointestinal and dermatological health worldwide. Thiabendazole tablets is available in Tablets and strengths such as 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Thiabendazole tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Thiabendazole tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Thiabendazole tablets, marketed as Mintezol and Tebanic, are approved in the US by the FDA and in the EU via EMA for treating parasitic infections. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper compliance supports timely approval, safe use, and global availability, effectively managing intestinal and skin parasitic infections worldwide, supporting health efforts against parasitic diseases.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Thiabendazole is used for treating parasitic infections such as strongyloidiasis, cutaneous larva migrans, and trichinosis. It works by inhibiting the parasite’s metabolic processes, ultimately destroying the worm. It has also been used as an antifungal agent in some cases.
Thiabendazole is made from the active ingredient thiabendazole, a synthetic benzimidazole derivative with broad-spectrum anthelmintic and antifungal activity.
A well-known trade name for Thiabendazole is Mintezol.
Mintezol was originally manufactured by Merck. Various generic manufacturers around the world also produce thiabendazole formulations.
The generic name is thiabendazole.
A commonly recognized brand name is Mintezol.
Thiabendazole is manufactured in multiple countries, including India, China, and several regions in Europe and the United States, where both branded and generic products are produced.
Related Products
Mefloquine Hydrochloride
Strength:
250 mg
Form: Tablets
Reference Brands: Lariam (USA/EU)
View Details
Diethylcarbamazine (Dec) Tablet
Strength:
100 mg
Form: Tablets
Reference Brands: Generic formulations available in various generic brands
View Details
Praziquantel Tablets
Strength:
600 mg
Form: Tablets
Reference Brands: Biltricide(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
